ReachMD

Be part of the knowledge.™

Pediatrics

43

LikeLikedUnlike

Episodes 1-15 of 25

- Danielle Becker, MD, MS, FAES
  Peer
- Ahmed Abdelmoity, MD
  Peer
- Deborah Holder, MD
  Peer
- John Stern, MD
  Peer
2
CME/CE
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
0.25 credits
- John D. Mahan, MD
  Peer
- Guido Filler, MD, PhD, FRCPC
  Peer
- Maria E. Díaz-González de Ferris, MD, MPH, PhD
  Peer
- Anne E. Dawson, PhD
  Peer
1
Minute CME/CE™
From Child to Adult: Successful Transitional Care for X-Linked Hypophosphatemia
1.50 credits 8 episodes
- Guido Filler, MD, PhD, FRCPC
  Peer
1
Minute CME/CE™
Individualized Treatment Approaches for Optimal Lifelong Management of Children and Adults with XLH
Individualized Treatment Approaches for Optimal Lifelong Management of Children and Adults with XLH
1.50 program credits
- John D. Mahan, MD
  Peer
- Guido Filler, MD, PhD, FRCPC
  Peer
1
Minute CME/CE™
Pediatric To Adult Care: A Team Effort
Pediatric To Adult Care: A Team Effort
1.50 program credits
- John D. Mahan, MD
  Peer
1
Minute CME/CE™
XLH: A Case of Bowed Legs - What Else Could It Be?
XLH: A Case of Bowed Legs - What Else Could It Be?
1.50 program credits
- John D. Mahan, MD
  Peer
2
Minute CME/CE™
XLH: An Uncommon But Treatable Disorder
XLH: An Uncommon But Treatable Disorder
1.50 program credits
- John D. Mahan, MD
  Peer
- Guido Filler, MD, PhD, FRCPC
  Peer
1
Minute CME/CE™
Best Practice for the Multidisciplinary Team – Starting Transition Early, Tailoring the Specific Timing and Speed to Individual Patients
Best Practice for the Multidisciplinary Team – Starting Transition Early, Tailoring the Specific Timing and Speed to Individual Patients
1.50 program credits
- Guido Filler, MD, PhD, FRCPC
  Peer
1
Minute CME/CE™
Continuing XLH Treatment into Adulthood – Evolving the Treatment Goals
Continuing XLH Treatment into Adulthood – Evolving the Treatment Goals
1.50 program credits
- Maria E. Díaz-González de Ferris, MD, MPH, PhD
  Peer
1
Minute CME/CE™
Healthcare Transition with XLH
Healthcare Transition with XLH
1.50 program credits
- Anne E. Dawson, PhD
  Peer
1
Minute CME/CE™
Psychosocial Considerations in Managing XLH
Psychosocial Considerations in Managing XLH
1.50 program credits
- Kara B. Markham, MD
  Peer
3
CME/CE
Hemolytic Disease of the Fetus and Newborn (HDFN): What Pediatric Providers Need to Know When Managing Hemolytic Disease in Newborns (HDN)
Hemolytic Disease of the Fetus and Newborn (HDFN): What Pediatric Providers Need to Know When Managing Hemolytic Disease in Newborns (HDN)
0.25 credits
- William Mencia, MD, FACEHP, CHCP
  Peer
- Julie Blatt, MD
  Peer
- Taizo Nakano, MD
  Peer
0
CME/CE
Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
0.50 credits
- Riten Kumar, MD, MSc
  Peer
0
Minute CME/CE™
What Do the Current Clinical Guidelines Recommend Regarding Post-acute Management of VTE in Pediatric Patients?
What Do the Current Clinical Guidelines Recommend Regarding Post-acute Management of VTE in Pediatric Patients?
1.50 program credits
- Riten Kumar, MD, MSc
  Peer
0
Minute CME/CE™
What Therapeutic Options Are Currently Available for Post-acute Anticoagulation Therapy To Prevent Recurrent VTE in Pediatric Patients?
What Therapeutic Options Are Currently Available for Post-acute Anticoagulation Therapy To Prevent Recurrent VTE in Pediatric Patients?
1.50 program credits
- Julie Jaffray, MD, MS
  Peer
2
Minute CME/CE™
The Prevalence and Severity of Recurrent VTE in Children
The Prevalence and Severity of Recurrent VTE in Children
1.50 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended